Proteomics Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032
Description
Persistence Market Research has recently released a comprehensive report on the worldwide market for proteomics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.
Key Insights: Proteomics Market
Proteomics is the large-scale study of proteins, including their structures, functions, interactions, and expression patterns within biological systems. It plays a pivotal role in life sciences research, drug discovery, biomarker identification, precision medicine, and disease diagnostics. The proteomics market serves pharmaceutical and biotechnology companies, academic and research institutes, clinical laboratories, and contract research organizations (CROs), offering a broad portfolio of instruments, reagents, consumables, and software solutions. Technologies such as mass spectrometry, protein microarrays, electrophoresis, and chromatography underpin proteomics workflows. Market growth is driven by expanding applications in personalized medicine, increasing investments in biomedical research, and continuous advancements in analytical technologies that improve sensitivity, throughput, and data accuracy.
Market Growth Drivers
The global proteomics market is propelled by several key factors, including the rising demand for personalized and precision medicine, where protein-based biomarkers enable more accurate disease diagnosis and therapy selection. Growing investments in pharmaceutical and biotechnology R&D, particularly in oncology, neurology, and immunology, further stimulate demand for advanced proteomic tools. Technological advancements in mass spectrometry, next-generation protein sequencing, and bioinformatics platforms have significantly enhanced protein identification and quantification, accelerating drug discovery and biomarker validation. Additionally, increasing government funding for life sciences research and the expanding role of proteomics in systems biology and clinical research continue to support sustained market expansion.
Market Restraints
Despite strong growth prospects, the proteomics market faces challenges related to high instrument costs, complex workflows, and data analysis bottlenecks. Advanced mass spectrometry systems and associated software require substantial capital investment and skilled personnel, limiting adoption among small and mid-sized laboratories, particularly in emerging economies. Furthermore, variability in sample preparation, lack of standardized protocols, and challenges in data interpretation and reproducibility can hinder broader clinical integration. Regulatory complexities associated with clinical proteomics applications and the need for robust validation of protein biomarkers also present barriers to rapid commercialization.
Market Opportunities
The proteomics market presents significant growth opportunities driven by technological innovation, expanding clinical applications, and the integration of multi-omics approaches. The convergence of proteomics with genomics, metabolomics, and transcriptomics enables deeper biological insights and supports the development of next-generation diagnostics and therapeutics. Advances in artificial intelligence (AI) and machine learning for proteomic data analysis enhance pattern recognition, biomarker discovery, and predictive modeling. Furthermore, the growing adoption of proteomics in drug development, companion diagnostics, and population-scale proteome projects, along with increasing demand from contract research and clinical testing services, creates new avenues for market players to expand their offerings and geographic footprint.
Key Questions Answered in the Report
Leading players in the global proteomics market, including Thermo Fisher Scientific Inc., Bruker Corporation, Agilent Technologies, and Danaher Corporation, focus on innovation, product differentiation, and strategic partnerships to strengthen their competitive positions. These companies invest heavily in R&D to develop high-resolution mass spectrometers, advanced chromatography systems, and integrated software platforms that streamline proteomics workflows. Collaborations with pharmaceutical companies, academic institutions, and clinical laboratories facilitate technology adoption and expand application areas. Emphasis on automation, cloud-based data analysis, and scalable solutions enables providers to meet the growing demand for high-throughput proteomics in drug discovery and precision medicine.
Key Companies Profiled
By Component
Please Note: It will take 5 business days to complete the report upon order confirmation.
Key Insights: Proteomics Market
- Market Size (2025E): US$ 41.0 Bn
- Projected Market Value (2032F): US$ 99.8 Bn
- Global Market Growth Rate (CAGR 2025 to 2032):13.6%
Proteomics is the large-scale study of proteins, including their structures, functions, interactions, and expression patterns within biological systems. It plays a pivotal role in life sciences research, drug discovery, biomarker identification, precision medicine, and disease diagnostics. The proteomics market serves pharmaceutical and biotechnology companies, academic and research institutes, clinical laboratories, and contract research organizations (CROs), offering a broad portfolio of instruments, reagents, consumables, and software solutions. Technologies such as mass spectrometry, protein microarrays, electrophoresis, and chromatography underpin proteomics workflows. Market growth is driven by expanding applications in personalized medicine, increasing investments in biomedical research, and continuous advancements in analytical technologies that improve sensitivity, throughput, and data accuracy.
Market Growth Drivers
The global proteomics market is propelled by several key factors, including the rising demand for personalized and precision medicine, where protein-based biomarkers enable more accurate disease diagnosis and therapy selection. Growing investments in pharmaceutical and biotechnology R&D, particularly in oncology, neurology, and immunology, further stimulate demand for advanced proteomic tools. Technological advancements in mass spectrometry, next-generation protein sequencing, and bioinformatics platforms have significantly enhanced protein identification and quantification, accelerating drug discovery and biomarker validation. Additionally, increasing government funding for life sciences research and the expanding role of proteomics in systems biology and clinical research continue to support sustained market expansion.
Market Restraints
Despite strong growth prospects, the proteomics market faces challenges related to high instrument costs, complex workflows, and data analysis bottlenecks. Advanced mass spectrometry systems and associated software require substantial capital investment and skilled personnel, limiting adoption among small and mid-sized laboratories, particularly in emerging economies. Furthermore, variability in sample preparation, lack of standardized protocols, and challenges in data interpretation and reproducibility can hinder broader clinical integration. Regulatory complexities associated with clinical proteomics applications and the need for robust validation of protein biomarkers also present barriers to rapid commercialization.
Market Opportunities
The proteomics market presents significant growth opportunities driven by technological innovation, expanding clinical applications, and the integration of multi-omics approaches. The convergence of proteomics with genomics, metabolomics, and transcriptomics enables deeper biological insights and supports the development of next-generation diagnostics and therapeutics. Advances in artificial intelligence (AI) and machine learning for proteomic data analysis enhance pattern recognition, biomarker discovery, and predictive modeling. Furthermore, the growing adoption of proteomics in drug development, companion diagnostics, and population-scale proteome projects, along with increasing demand from contract research and clinical testing services, creates new avenues for market players to expand their offerings and geographic footprint.
Key Questions Answered in the Report
- What are the primary factors driving the growth of the proteomics market globally?
- Which technologies and applications are fueling adoption across research, pharmaceutical, and clinical settings?
- How are advancements in mass spectrometry, automation, and bioinformatics reshaping the competitive landscape of the proteomics market?
- Who are the key players contributing to the proteomics market, and what strategies are they employing to maintain market relevance?
- What are the emerging trends and future prospects in the global proteomics market?
Leading players in the global proteomics market, including Thermo Fisher Scientific Inc., Bruker Corporation, Agilent Technologies, and Danaher Corporation, focus on innovation, product differentiation, and strategic partnerships to strengthen their competitive positions. These companies invest heavily in R&D to develop high-resolution mass spectrometers, advanced chromatography systems, and integrated software platforms that streamline proteomics workflows. Collaborations with pharmaceutical companies, academic institutions, and clinical laboratories facilitate technology adoption and expand application areas. Emphasis on automation, cloud-based data analysis, and scalable solutions enables providers to meet the growing demand for high-throughput proteomics in drug discovery and precision medicine.
Key Companies Profiled
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc. (Olink)
- Cell Signaling Technology, Inc.
- Bruker
- Illumina, Inc.
- Beckman Coulter, Inc.
- DH Life Sciences, LLC (Danaher)
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Waters Corporation
- Promega Corporation
- Quantum-Si Incorporated
- Nomic
- Seer, Inc
- Alamar Biosciences, Inc.
- Nautilus Biotechnology Inc.
- Proteomics International
- PreOmics GmbH
- SomaLogic Operating Co., Inc.
- Proteome Factory AG
By Component
- Instruments
- Reagents & Kits
- Software and Services
- Protein Microarray
- X-Ray Crystallography
- Spectroscopy
- Chromatography
- Protein Fractionation
- Electrophoresis
- Surface Plasma Resonance
- Drug Discovery & Development
- Clinical Diagnostics
- Cancer Research
- Personalized Medicine
- Biotech & Pharma Companies
- Contract Research Organization (CROs)
- Academic & Research Institutions
- Hospitals & Clinical Laboratories
- North America
- Europe
- East Asia
- South Asia and Oceania
- Latin America
- Middle East & Africa
Please Note: It will take 5 business days to complete the report upon order confirmation.
Table of Contents
247 Pages
- 1. Executive Summary
- 1.1. Global Proteomics Market Snapshot, 2025 and 2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
- 2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
- 2.4. COVID-19 Impact Analysis
- 2.5. Forecast Factors - Relevance and Impact
- 3. Value Added Insights
- 3.1. Product Adoption Analysis
- 3.2. Disease Epidemiology, Key Indications
- 3.3. Regulatory Landscape
- 3.4. PESTLE Analysis
- 3.5. Porter’s Five Force Analysis
- 3.6. Promotional Strategies, By Key Players
- 4. Global Proteomics Market Outlook
- 4.1. Key Highlights
- 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
- 4.2. Market Size (US$ Bn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
- 4.3. Global Proteomics Market Outlook: Component
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn) Analysis, By Component, 2019-2024
- 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Component, 2025-2032
- 4.3.3.1. Instruments
- 4.3.3.2. Reagents & Kits
- 4.3.3.3. Software and Services
- 4.3.4. Market Attractiveness Analysis: Component
- 4.4. Global Proteomics Market Outlook: Technique
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Bn), By Technique, 2019-2024
- 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Technique, 2025-2032
- 4.4.3.1. Protein Microarray
- 4.4.3.2. X-Ray Crystallography
- 4.4.3.3. Spectroscopy
- 4.4.3.4. Chromatography
- 4.4.3.5. Protein Fractionation
- 4.4.3.6. Electrophoresis
- 4.4.3.7. Surface Plasma Resonance
- 4.4.3.8. Others
- 4.4.4. Market Attractiveness Analysis: Technique
- 4.5. Global Proteomics Market Outlook: Application
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Bn), By Application, 2019-2024
- 4.5.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 4.5.3.1. Drug Discovery & Development
- 4.5.3.2. Clinical Diagnostics
- 4.5.3.3. Cancer Research
- 4.5.3.4. Personalized Medicine
- 4.5.3.5. Others
- 4.5.4. Market Attractiveness Analysis: Application
- 4.6. Global Proteomics Market Outlook: End User
- 4.6.1. Introduction / Key Findings
- 4.6.2. Historical Market Size (US$ Bn), By End User, 2019-2024
- 4.6.3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
- 4.6.3.1. Biotech & Pharma Companies
- 4.6.3.2. Contract Research Organization (CROs)
- 4.6.3.3. Academic & Research Institutions
- 4.6.3.4. Hospitals & Clinical Laboratories
- 4.6.3.5. Others
- 4.6.4. Market Attractiveness Analysis: End User
- 5. Global Proteomics Market Outlook: Region
- 5.1. Key Highlights
- 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
- 5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
- 5.4. Market Attractiveness Analysis: Region
- 6. North America Proteomics Market Outlook
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 6.2.1. By Country
- 6.2.2. By Component
- 6.2.3. By Technique
- 6.2.4. By Application
- 6.2.5. By End User
- 6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 6.3.1. U.S.
- 6.3.2. Canada
- 6.4. Market Size (US$ Bn) Analysis and Forecast, By Component, 2025-2032
- 6.4.1. Instruments
- 6.4.2. Reagents & Kits
- 6.4.3. Software and Services
- 6.5. Market Size (US$ Bn) Analysis and Forecast, By Technique, 2025-2032
- 6.5.1. Protein Microarray
- 6.5.2. X-Ray Crystallography
- 6.5.3. Spectroscopy
- 6.5.4. Chromatography
- 6.5.5. Protein Fractionation
- 6.5.6. Electrophoresis
- 6.5.7. Surface Plasma Resonance
- 6.5.8. Others
- 6.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 6.6.1. Drug Discovery & Development
- 6.6.2. Clinical Diagnostics
- 6.6.3. Cancer Research
- 6.6.4. Personalized Medicine
- 6.6.5. Others
- 6.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
- 6.7.1. Biotech & Pharma Companies
- 6.7.2. Contract Research Organization (CROs)
- 6.7.3. Academic & Research Institutions
- 6.7.4. Hospitals & Clinical Laboratories
- 6.7.5. Others
- 6.8. Market Attractiveness Analysis
- 7. Europe Proteomics Market Outlook
- 7.1. Key Highlights
- 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Component
- 7.2.3. By Technique
- 7.2.4. By Application
- 7.2.5. By End User
- 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
- 7.4. Market Size (US$ Bn) Analysis and Forecast, By Component, 2025-2032
- 7.4.1. Instruments
- 7.4.2. Reagents & Kits
- 7.4.3. Software and Services
- 7.5. Market Size (US$ Bn) Analysis and Forecast, By Technique, 2025-2032
- 7.5.1. Protein Microarray
- 7.5.2. X-Ray Crystallography
- 7.5.3. Spectroscopy
- 7.5.4. Chromatography
- 7.5.5. Protein Fractionation
- 7.5.6. Electrophoresis
- 7.5.7. Surface Plasma Resonance
- 7.5.8. Others
- 7.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 7.6.1. Drug Discovery & Development
- 7.6.2. Clinical Diagnostics
- 7.6.3. Cancer Research
- 7.6.4. Personalized Medicine
- 7.6.5. Others
- 7.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
- 7.7.1. Biotech & Pharma Companies
- 7.7.2. Contract Research Organization (CROs)
- 7.7.3. Academic & Research Institutions
- 7.7.4. Hospitals & Clinical Laboratories
- 7.7.5. Others
- 7.8. Market Attractiveness Analysis
- 8. East Asia Proteomics Market Outlook
- 8.1. Key Highlights
- 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Component
- 8.2.3. By Technique
- 8.2.4. By Application
- 8.2.5. By End User
- 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
- 8.4. Market Size (US$ Bn) Analysis and Forecast, By Component, 2025-2032
- 8.4.1. Instruments
- 8.4.2. Reagents & Kits
- 8.4.3. Software and Services
- 8.5. Market Size (US$ Bn) Analysis and Forecast, By Technique, 2025-2032
- 8.5.1. Protein Microarray
- 8.5.2. X-Ray Crystallography
- 8.5.3. Spectroscopy
- 8.5.4. Chromatography
- 8.5.5. Protein Fractionation
- 8.5.6. Electrophoresis
- 8.5.7. Surface Plasma Resonance
- 8.5.8. Others
- 8.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 8.6.1. Drug Discovery & Development
- 8.6.2. Clinical Diagnostics
- 8.6.3. Cancer Research
- 8.6.4. Personalized Medicine
- 8.6.5. Others
- 8.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
- 8.7.1. Biotech & Pharma Companies
- 8.7.2. Contract Research Organization (CROs)
- 8.7.3. Academic & Research Institutions
- 8.7.4. Hospitals & Clinical Laboratories
- 8.7.5. Others
- 8.8. Market Attractiveness Analysis
- 9. South Asia & Oceania Proteomics Market Outlook
- 9.1. Key Highlights
- 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Component
- 9.2.3. By Technique
- 9.2.4. By Application
- 9.2.5. By End User
- 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
- 9.4. Market Size (US$ Bn) Analysis and Forecast, By Component, 2025-2032
- 9.4.1. Instruments
- 9.4.2. Reagents & Kits
- 9.4.3. Software and Services
- 9.5. Market Size (US$ Bn) Analysis and Forecast, By Technique, 2025-2032
- 9.5.1. Protein Microarray
- 9.5.2. X-Ray Crystallography
- 9.5.3. Spectroscopy
- 9.5.4. Chromatography
- 9.5.5. Protein Fractionation
- 9.5.6. Electrophoresis
- 9.5.7. Surface Plasma Resonance
- 9.5.8. Others
- 9.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 9.6.1. Drug Discovery & Development
- 9.6.2. Clinical Diagnostics
- 9.6.3. Cancer Research
- 9.6.4. Personalized Medicine
- 9.6.5. Others
- 9.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
- 9.7.1. Biotech & Pharma Companies
- 9.7.2. Contract Research Organization (CROs)
- 9.7.3. Academic & Research Institutions
- 9.7.4. Hospitals & Clinical Laboratories
- 9.7.5. Others
- 9.8. Market Attractiveness Analysis
- 10. Latin America Proteomics Market Outlook
- 10.1. Key Highlights
- 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Component
- 10.2.3. By Technique
- 10.2.4. By Application
- 10.2.5. By End User
- 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
- 10.4. Market Size (US$ Bn) Analysis and Forecast, By Component, 2025-2032
- 10.4.1. Instruments
- 10.4.2. Reagents & Kits
- 10.4.3. Software and Services
- 10.5. Market Size (US$ Bn) Analysis and Forecast, By Technique, 2025-2032
- 10.5.1. Protein Microarray
- 10.5.2. X-Ray Crystallography
- 10.5.3. Spectroscopy
- 10.5.4. Chromatography
- 10.5.5. Protein Fractionation
- 10.5.6. Electrophoresis
- 10.5.7. Surface Plasma Resonance
- 10.5.8. Others
- 10.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 10.6.1. Drug Discovery & Development
- 10.6.2. Clinical Diagnostics
- 10.6.3. Cancer Research
- 10.6.4. Personalized Medicine
- 10.6.5. Others
- 10.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
- 10.7.1. Biotech & Pharma Companies
- 10.7.2. Contract Research Organization (CROs)
- 10.7.3. Academic & Research Institutions
- 10.7.4. Hospitals & Clinical Laboratories
- 10.7.5. Others
- 10.8. Market Attractiveness Analysis
- 11. Middle East & Africa Proteomics Market Outlook
- 11.1. Key Highlights
- 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Component
- 11.2.3. By Technique
- 11.2.4. By Application
- 11.2.5. By End User
- 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
- 11.4. Market Size (US$ Bn) Analysis and Forecast, By Component, 2025-2032
- 11.4.1. Instruments
- 11.4.2. Reagents & Kits
- 11.4.3. Software and Services
- 11.5. Market Size (US$ Bn) Analysis and Forecast, By Technique, 2025-2032
- 11.5.1. Protein Microarray
- 11.5.2. X-Ray Crystallography
- 11.5.3. Spectroscopy
- 11.5.4. Chromatography
- 11.5.5. Protein Fractionation
- 11.5.6. Electrophoresis
- 11.5.7. Surface Plasma Resonance
- 11.5.8. Others
- 11.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 11.6.1. Drug Discovery & Development
- 11.6.2. Clinical Diagnostics
- 11.6.3. Cancer Research
- 11.6.4. Personalized Medicine
- 11.6.5. Others
- 11.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
- 11.7.1. Biotech & Pharma Companies
- 11.7.2. Contract Research Organization (CROs)
- 11.7.3. Academic & Research Institutions
- 11.7.4. Hospitals & Clinical Laboratories
- 11.7.5. Others
- 11.8. Market Attractiveness Analysis
- 12. Competition Landscape
- 12.1. Market Share Analysis, 2024
- 12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
- 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Agilent Technologies, Inc.
- 12.3.1.1. Overview
- 12.3.1.2. Segments and Products
- 12.3.1.3. Key Financials
- 12.3.1.4. Market Developments
- 12.3.1.5. Market Strategy
- 12.3.2. Thermo Fisher Scientific, Inc. (Olink)
- 12.3.3. Cell Signaling Technology, Inc.
- 12.3.4. Bruker
- 12.3.5. Illumina, Inc.
- 12.3.6. Beckman Coulter, Inc.
- 12.3.7. DH Life Sciences, LLC (Danaher)
- 12.3.8. Merck KGaA
- 12.3.9. Bio-Rad Laboratories, Inc.
- 12.3.10. Waters Corporation
- 12.3.11. Promega Corporation
- 12.3.12. Quantum-Si Incorporated
- 12.3.13. Nomic
- 12.3.14. Seer, Inc
- 12.3.15. Alamar Biosciences, Inc.
- 12.3.16. Nautilus Biotechnology Inc.
- 12.3.17. Proteomics International
- 12.3.18. PreOmics GmbH
- 12.3.19. SomaLogic Operating Co., Inc.
- 12.3.20. Proteome Factory AG
- 13. Appendix
- 13.1. Research Methodology
- 13.2. Research Assumptions
- 13.3. Acronyms and Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
